Does Pharmacological Treatment of Neuropsychiatric Symptoms in Alzheimer's Disease Relieve Caregiver Burden?

Author： Levy Karen   Lanctôt Krista L.   Farber Shale B.   Li Abby   Herrmann Nathan  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.29, Iss.3, 2012-03, pp. : 167-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Economic Impact of Neuropsychiatric Symptoms in Alzheimer’s Disease: Can Drugs Ease the Burden?

By Murman Daniel L.  

PharmacoEconomics, Vol. 23, Iss. 3, 2005-01 ,pp. : 227-242

Adis International

Access to resources Recommend Favorite

Efficacy of praziquantel correlated to disease burden?

By  

Inpharma, Vol. 1, Iss. 1229, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Pharmacological Treatment of the Psychosis of Alzheimer's Disease: What Is the Best Approach?

By Madhusoodanan Subramoniam   Shah Payal   Brenner Ronald   Gupta Sanjay  

CNS Drugs, Vol. 21, Iss. 2, 2007-01 ,pp. : 101-115

Adis International

Access to resources Recommend Favorite

Pharmacological Treatment of Cognitive Symptoms in Alzheimer's Disease

By  

Current Psychopharmacology, Vol. 3, Iss. 1, 2014-04 ,pp. : 59-66

Bentham Science Publishers

Access to resources Recommend Favorite

Does Lithium Prevent Alzheimer's Disease?

By Forlenza Orestes V.   de Paula Vanessa J.   Machado-Vieira Rodrigo   Diniz Breno S.   Gattaz Wagner F.  

Drugs & Aging, Vol. 29, Iss. 5, 2012-05 ,pp. : 335-342

Adis International

Access to resources Recommend Favorite